Ad
Thursday, 6 April 2017
FDA allows 23andMe to sell genetic tests for 10 diseases
(Reuters) - The U.S. Food and Drug Administration on Thursday agreed to allow genetic testing company 23andMe to market tests directly to consumers for their predisposition to 10 diseases, including Parkinson's, Alzheimer's and Celiac disease.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment